Fluoride treatment increased serum IGF-1, bone turnover, and bone mass, but not bone strength, in rabbits

C. H. Turner, L. P. Garetto, A. J. Dunipace, W. Zhang, M. E. Wilson, M. D. Grynpas, D. Chachra, R. McClintock, Munro Peacock, G. K. Stookey

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

We hypothesized that fluoride partly acts by changing the levels of circulating calcium-regulating hormones and skeletal growth factors. The effects of oral fluoride on 24 female, Dutch-Belted, young adult rabbits were studied. The rabbits were divided into two study groups, one control and the other receiving about 16 mg fluoride/rabbit/day in their drinking water. After 6 months of fluoride dosing, all rabbits were euthanized and bone and blood samples were taken for analyses. Fluoride treatment increased serum and bone fluoride levels by over an order of magnitude (P < 0.001), but did not affect body weight or the following serum biochemical variables: urea, creatinine, phosphorus, total protein, albumin, bilirubin, SGOT, or total alkaline phosphatase. No skeletal fluorosis or osteomalacia was observed histologically, nor did fluoride affect serum PTH or Vitamin D metabolites (P > 0.4). BAP was increased 37% (P < 0.05) by fluoride; serum TRAP was increased 42% (P < 0.05); serum IGF-1 was increased 40% (P < 0.05). Fluoride increased the vertebral BV/TV by 35% (P < 0.05) and tibial ash weight by 10% (P < 0.05). However, the increases in bone mass and hone formation were not reflected in improved bone strength. Fluoride decreased bone strength by about 19% in the L5 vertebra (P < 0.01) and 25% in the femoral neck (P < 0.05). X-ray diffraction showed altered mineral crystal thickness in fluoride-treated bones (P < 0.001), and there was a negative association between crystal width and fracture stress of the femur (P < 0.02). In conclusion, fluoride's effects on bone mass and bone turnover were not mediated by PTH. IGF-1 was increased by fluoride and was associated with increased bone turnover, but was not correlated with bone formation markers. High-dose fluoride treatment did not improve, but decreased, bone strength in rabbits, even in the absence of impaired mineralization.

Original languageEnglish
Pages (from-to)77-83
Number of pages7
JournalCalcified Tissue International
Volume61
Issue number1
DOIs
StatePublished - Jul 1997

Fingerprint

Bone Remodeling
Fluorides
Insulin-Like Growth Factor I
Rabbits
Bone and Bones
Serum
Therapeutics
Stress Fractures
Femur Neck
Osteogenesis
X-Ray Diffraction
Drinking Water
Femur
Minerals
Young Adult
Intercellular Signaling Peptides and Proteins
Spine

Keywords

  • Biomechanics
  • Bone
  • Bone density
  • Fluoride
  • IGF-1
  • Mineralization

ASJC Scopus subject areas

  • Endocrinology

Cite this

Turner, C. H., Garetto, L. P., Dunipace, A. J., Zhang, W., Wilson, M. E., Grynpas, M. D., ... Stookey, G. K. (1997). Fluoride treatment increased serum IGF-1, bone turnover, and bone mass, but not bone strength, in rabbits. Calcified Tissue International, 61(1), 77-83. https://doi.org/10.1007/s002239900299

Fluoride treatment increased serum IGF-1, bone turnover, and bone mass, but not bone strength, in rabbits. / Turner, C. H.; Garetto, L. P.; Dunipace, A. J.; Zhang, W.; Wilson, M. E.; Grynpas, M. D.; Chachra, D.; McClintock, R.; Peacock, Munro; Stookey, G. K.

In: Calcified Tissue International, Vol. 61, No. 1, 07.1997, p. 77-83.

Research output: Contribution to journalArticle

Turner, CH, Garetto, LP, Dunipace, AJ, Zhang, W, Wilson, ME, Grynpas, MD, Chachra, D, McClintock, R, Peacock, M & Stookey, GK 1997, 'Fluoride treatment increased serum IGF-1, bone turnover, and bone mass, but not bone strength, in rabbits', Calcified Tissue International, vol. 61, no. 1, pp. 77-83. https://doi.org/10.1007/s002239900299
Turner, C. H. ; Garetto, L. P. ; Dunipace, A. J. ; Zhang, W. ; Wilson, M. E. ; Grynpas, M. D. ; Chachra, D. ; McClintock, R. ; Peacock, Munro ; Stookey, G. K. / Fluoride treatment increased serum IGF-1, bone turnover, and bone mass, but not bone strength, in rabbits. In: Calcified Tissue International. 1997 ; Vol. 61, No. 1. pp. 77-83.
@article{9c94162f6516412aa39fd5436cb7fe44,
title = "Fluoride treatment increased serum IGF-1, bone turnover, and bone mass, but not bone strength, in rabbits",
abstract = "We hypothesized that fluoride partly acts by changing the levels of circulating calcium-regulating hormones and skeletal growth factors. The effects of oral fluoride on 24 female, Dutch-Belted, young adult rabbits were studied. The rabbits were divided into two study groups, one control and the other receiving about 16 mg fluoride/rabbit/day in their drinking water. After 6 months of fluoride dosing, all rabbits were euthanized and bone and blood samples were taken for analyses. Fluoride treatment increased serum and bone fluoride levels by over an order of magnitude (P < 0.001), but did not affect body weight or the following serum biochemical variables: urea, creatinine, phosphorus, total protein, albumin, bilirubin, SGOT, or total alkaline phosphatase. No skeletal fluorosis or osteomalacia was observed histologically, nor did fluoride affect serum PTH or Vitamin D metabolites (P > 0.4). BAP was increased 37{\%} (P < 0.05) by fluoride; serum TRAP was increased 42{\%} (P < 0.05); serum IGF-1 was increased 40{\%} (P < 0.05). Fluoride increased the vertebral BV/TV by 35{\%} (P < 0.05) and tibial ash weight by 10{\%} (P < 0.05). However, the increases in bone mass and hone formation were not reflected in improved bone strength. Fluoride decreased bone strength by about 19{\%} in the L5 vertebra (P < 0.01) and 25{\%} in the femoral neck (P < 0.05). X-ray diffraction showed altered mineral crystal thickness in fluoride-treated bones (P < 0.001), and there was a negative association between crystal width and fracture stress of the femur (P < 0.02). In conclusion, fluoride's effects on bone mass and bone turnover were not mediated by PTH. IGF-1 was increased by fluoride and was associated with increased bone turnover, but was not correlated with bone formation markers. High-dose fluoride treatment did not improve, but decreased, bone strength in rabbits, even in the absence of impaired mineralization.",
keywords = "Biomechanics, Bone, Bone density, Fluoride, IGF-1, Mineralization",
author = "Turner, {C. H.} and Garetto, {L. P.} and Dunipace, {A. J.} and W. Zhang and Wilson, {M. E.} and Grynpas, {M. D.} and D. Chachra and R. McClintock and Munro Peacock and Stookey, {G. K.}",
year = "1997",
month = "7",
doi = "10.1007/s002239900299",
language = "English",
volume = "61",
pages = "77--83",
journal = "Calcified Tissue International",
issn = "0171-967X",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Fluoride treatment increased serum IGF-1, bone turnover, and bone mass, but not bone strength, in rabbits

AU - Turner, C. H.

AU - Garetto, L. P.

AU - Dunipace, A. J.

AU - Zhang, W.

AU - Wilson, M. E.

AU - Grynpas, M. D.

AU - Chachra, D.

AU - McClintock, R.

AU - Peacock, Munro

AU - Stookey, G. K.

PY - 1997/7

Y1 - 1997/7

N2 - We hypothesized that fluoride partly acts by changing the levels of circulating calcium-regulating hormones and skeletal growth factors. The effects of oral fluoride on 24 female, Dutch-Belted, young adult rabbits were studied. The rabbits were divided into two study groups, one control and the other receiving about 16 mg fluoride/rabbit/day in their drinking water. After 6 months of fluoride dosing, all rabbits were euthanized and bone and blood samples were taken for analyses. Fluoride treatment increased serum and bone fluoride levels by over an order of magnitude (P < 0.001), but did not affect body weight or the following serum biochemical variables: urea, creatinine, phosphorus, total protein, albumin, bilirubin, SGOT, or total alkaline phosphatase. No skeletal fluorosis or osteomalacia was observed histologically, nor did fluoride affect serum PTH or Vitamin D metabolites (P > 0.4). BAP was increased 37% (P < 0.05) by fluoride; serum TRAP was increased 42% (P < 0.05); serum IGF-1 was increased 40% (P < 0.05). Fluoride increased the vertebral BV/TV by 35% (P < 0.05) and tibial ash weight by 10% (P < 0.05). However, the increases in bone mass and hone formation were not reflected in improved bone strength. Fluoride decreased bone strength by about 19% in the L5 vertebra (P < 0.01) and 25% in the femoral neck (P < 0.05). X-ray diffraction showed altered mineral crystal thickness in fluoride-treated bones (P < 0.001), and there was a negative association between crystal width and fracture stress of the femur (P < 0.02). In conclusion, fluoride's effects on bone mass and bone turnover were not mediated by PTH. IGF-1 was increased by fluoride and was associated with increased bone turnover, but was not correlated with bone formation markers. High-dose fluoride treatment did not improve, but decreased, bone strength in rabbits, even in the absence of impaired mineralization.

AB - We hypothesized that fluoride partly acts by changing the levels of circulating calcium-regulating hormones and skeletal growth factors. The effects of oral fluoride on 24 female, Dutch-Belted, young adult rabbits were studied. The rabbits were divided into two study groups, one control and the other receiving about 16 mg fluoride/rabbit/day in their drinking water. After 6 months of fluoride dosing, all rabbits were euthanized and bone and blood samples were taken for analyses. Fluoride treatment increased serum and bone fluoride levels by over an order of magnitude (P < 0.001), but did not affect body weight or the following serum biochemical variables: urea, creatinine, phosphorus, total protein, albumin, bilirubin, SGOT, or total alkaline phosphatase. No skeletal fluorosis or osteomalacia was observed histologically, nor did fluoride affect serum PTH or Vitamin D metabolites (P > 0.4). BAP was increased 37% (P < 0.05) by fluoride; serum TRAP was increased 42% (P < 0.05); serum IGF-1 was increased 40% (P < 0.05). Fluoride increased the vertebral BV/TV by 35% (P < 0.05) and tibial ash weight by 10% (P < 0.05). However, the increases in bone mass and hone formation were not reflected in improved bone strength. Fluoride decreased bone strength by about 19% in the L5 vertebra (P < 0.01) and 25% in the femoral neck (P < 0.05). X-ray diffraction showed altered mineral crystal thickness in fluoride-treated bones (P < 0.001), and there was a negative association between crystal width and fracture stress of the femur (P < 0.02). In conclusion, fluoride's effects on bone mass and bone turnover were not mediated by PTH. IGF-1 was increased by fluoride and was associated with increased bone turnover, but was not correlated with bone formation markers. High-dose fluoride treatment did not improve, but decreased, bone strength in rabbits, even in the absence of impaired mineralization.

KW - Biomechanics

KW - Bone

KW - Bone density

KW - Fluoride

KW - IGF-1

KW - Mineralization

UR - http://www.scopus.com/inward/record.url?scp=0030913515&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030913515&partnerID=8YFLogxK

U2 - 10.1007/s002239900299

DO - 10.1007/s002239900299

M3 - Article

C2 - 9192519

AN - SCOPUS:0030913515

VL - 61

SP - 77

EP - 83

JO - Calcified Tissue International

JF - Calcified Tissue International

SN - 0171-967X

IS - 1

ER -